Thiamine responsive megaloblastic anemia syndrome. - <a href="../public/authorSummary-Ganesh, Ramaswamy.do">Ramaswamy Ganesh</a>, <a href="../public/authorSummary-Ezhilarasi, S.do">S Ezhilarasi</a>, <a href="../public/authorSummary-Vasanthi, Thiruvengadam.do">Thiruvengadam Vasanthi</a>, <a href="../public/authorSummary-Gowrishankar, Kalpana.do">Kalpana Gowrishankar</a>, <a href="../public/authorSummary-Rajajee, Sarala.do">Sarala Rajajee</a>

Abstract	Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness. We report a 4-year-old girl with TRMA whose anemia improved following administration of thiamine and this case report sensitizes the early diagnosis and treatment with thiamine in children presenting with anemia, diabetes and deafness.
Authors	Ramaswamy Ganesh, S Ezhilarasi, Thiruvengadam Vasanthi, Kalpana Gowrishankar, Sarala Rajajee
Journal	Indian journal of pediatrics (Indian J Pediatr) Vol. 76 Issue 3 Pg. 313-4 (Mar 2009) ISSN: 0973-7693 [Electronic] India
PMID	19347672 (Publication Type: Case Reports, Journal Article)
Chemical References	Blood Glucose Thiamine
Topics	Anemia, Megaloblastic (complications, diagnosis, drug therapy, genetics) Blood Glucose (metabolism) Child, Preschool Diabetes Mellitus, Type 1 (complications, genetics) Female Follow-Up Studies Hearing Loss, Sensorineural (complications, genetics) Humans Syndrome Thiamine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!